Meghan E. McCormick

Meghan E. McCormick is a Senior Associate of Boucher LLP in the firm’s San Francisco office. For nearly two decades, Meghan has passionately advocated for individuals harmed by the wrongful conduct of corporations, defective products, and more recently, institutions such as the Catholic Church. Her practice encompasses both complex mass tort matters and individual personal injury cases in both federal and state court.

Meghan represents survivors of child sexual abuse and adult victims of sexual assault, seeking to hold the responsible institutions accountable. In addition to seeking justice on behalf of sexual assault and sexual abuse survivors, Meghan represents individuals harmed by defective products and medical devices, including the Philips CPAP machines recalled in June 2021.

Prior to joining Boucher LLP, Meghan represented hundreds of women who were sexually assaulted by an Uber or Lyft driver. She was instrumental in the formation of the California Judicial Council Coordination Proceedings (JCCPs) In re Lyft Assault Cases and In re Uber Sexual Assault Cases. Meghan has also represented thousands of clients harmed by defective and or dangerous pharmaceutical products, including Zyprexa, Ortho Evra, Bextra, Celebrex, Accutane, Yaz/Yasmin, Byetta, Reglan, SSRI antidepressants, Actonel, Fosamax, Polident and Fixodent Denture Cream, AMS, Bard, Ethicon and Boston Scientific transvaginal mesh products. Meghan actively worked with the plaintiffs’ steering committee for several multidistrict litigations (MDLs), including the Zyprexa MDL (E.D.N.Y.), the Ortho Evra MDL (N.D. Ohio), the Yaz/Yasmin MDL (S.D. Ill.), the Fosamax MDL (S.D.N.Y.), and the Bard, Ethicon, Boston Scientific and AMS Transvaginal Mesh MDLs (S.D.W. Va.).

Meghan was on the trial team for several trials against Pharmaceutical giant Merck in relation to its osteoporosis drug Fosamax, including one of the first Fosamax MDL trials, the only one of which that resulted in a plaintiff’s verdict─ Boles v. Merck. After a hung jury with the first trial, the second trial resulted in the jury awarding the 72-year-old plaintiff, Shirley Boles, $8 million in compensatory damages.

Over the course of her career, Meghan has spoken at several seminars and conferences regarding the scientific and discovery issues involved in the various pharmaceutical cases she has worked on.

Meghan earned her law degree at the University of Wisconsin and her bachelor’s degree from Northwestern University where she graduated cum laude. While at Northwestern, Ms. McCormick played on the Northwestern Women’s Golf Team, earning Academic All Big Ten and Academic All-American honors. Upon graduating from law school, Meghan clerked for the Honorable Justice James Gilbert of the Minnesota Supreme Court. Past law firms include Fredrikson & Byron P.A., Levin Papantonio Rafferty, P.A., The Sizemore Law Firm, and Levin Simes Abrams LLP.

Meghan is licensed to practice in Wisconsin (inactive), Minnesota (inactive), Florida and California. She is an active member of the American Association for Justice and the San Francisco Trial Lawyers Association.